sellWeak cluster of 210b5-1 plan
PREVOZNIK MICHAEL E sold $5.7M of DGX
SVP & General Counsel at QUEST DIAGNOSTICS INC. 35,146 shares at an average of $163.07, traded Nov 29, 2024, filed Dec 2, 2024.
Warning score
23Value
$5.7M
35,146 shares
Holdings after
38,478
-48% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001022079-24-000208, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 29, 2024 | MOption exercise Common Stock10b5-1 | +35,146 | $86.63 | $3.0M | 73,624 | Dec 2, 2024 |
| Nov 29, 2024 | SOpen-market sale Common Stock10b5-1 | -3,009 | $162.26 | $488k | 70,615 | Dec 2, 2024 |
| Nov 29, 2024 | SOpen-market sale Common Stock10b5-1 | -32,137 | $163.15 | $5.2M | 38,478 | Dec 2, 2024 |
| Nov 29, 2024 | MOption exercise Non-Qualifed Stock Option (right to buy)derivative10b5-1 | -35,146 | $86.63 | $3.0M | 0 | Dec 2, 2024 |
Related signals
Other insiders at QUEST DIAGNOSTICS INC and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 23Weak | sell 210b5-1 | DGX QUEST DIAGNOSTICS INC | Doherty Catherine T. EVP, Regional Businesses | $5.4M | 33,103 | |
| 23Weak | sell 210b5-1 | DGX QUEST DIAGNOSTICS INC | DEPPE MICHAEL J SVP, Corp. Controller & CAO | $2.9M | 18,755 | |
| 42Moderate | sell 2 | DGX QUEST DIAGNOSTICS INC | KUPPUSAMY KARTHIK SVP, Clinical Solutions | $279k | 1,775 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.